Equities Analysts Offer Predictions for THC FY2025 Earnings

Tenet Healthcare Corporation (NYSE:THC) – Analysts at Zacks Research upped their FY2025 earnings estimates for Tenet Healthcare in a report issued on Tuesday, November 11th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $16.10 for the year, up from their prior estimate of $15.61. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.78 EPS, Q4 2026 earnings at $4.22 EPS and Q2 2027 earnings at $4.71 EPS.

Tenet Healthcare (NYSE:THC) last released its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The firm had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS.

THC has been the subject of several other research reports. Royal Bank Of Canada increased their price target on Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Mizuho increased their target price on shares of Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a research report on Friday, October 17th. Cantor Fitzgerald boosted their price target on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Morgan Stanley set a $232.00 price objective on shares of Tenet Healthcare and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Finally, Robert W. Baird dropped their target price on Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $226.25.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $200.08 on Thursday. The firm has a market cap of $17.58 billion, a price-to-earnings ratio of 13.71, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53. The stock has a fifty day simple moving average of $198.89 and a two-hundred day simple moving average of $177.72. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.27. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $217.43.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors have recently made changes to their positions in THC. Xponance Inc. lifted its holdings in shares of Tenet Healthcare by 1.1% during the 1st quarter. Xponance Inc. now owns 11,053 shares of the company’s stock worth $1,487,000 after acquiring an additional 124 shares during the last quarter. CWM LLC lifted its stake in Tenet Healthcare by 10.6% during the first quarter. CWM LLC now owns 6,888 shares of the company’s stock worth $926,000 after purchasing an additional 659 shares during the last quarter. MQS Management LLC bought a new position in shares of Tenet Healthcare during the 1st quarter valued at about $218,000. Victory Capital Management Inc. raised its holdings in shares of Tenet Healthcare by 45.2% during the 1st quarter. Victory Capital Management Inc. now owns 736,252 shares of the company’s stock valued at $99,026,000 after buying an additional 229,197 shares in the last quarter. Finally, Diversify Advisory Services LLC bought a new stake in Tenet Healthcare in the 1st quarter worth approximately $230,000. Institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, Director Christopher S. Lynch sold 3,952 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $176.39, for a total value of $697,093.28. Following the transaction, the director owned 12,358 shares of the company’s stock, valued at approximately $2,179,827.62. This represents a 24.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Lisa Y. Foo sold 8,000 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president owned 20,878 shares of the company’s stock, valued at approximately $3,748,227.34. The trade was a 27.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 134,044 shares of company stock worth $25,977,997. Company insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.